Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ConVergInce Advisers is a strategic consulting firm specializing in the commercialization of industrial biotechnology, renewable chemicals, and biobased materials. Founded in 2010 and led by President Joel Stone, the firm provides expertise in strategic planning, business development, and technology evaluation for startups and established companies in the emerging bioeconomy. ConVergInce works closely with clients to scale up synthetic biology processes and optimize biorefining operations for the production of biochemicals, biofuels, and biobased food ingredients. The firm operates as a strategic partner with Lee Enterprises Consulting, leveraging a global network of experts to support sustainable innovation across the specialty and performance chemicals industries. Their services are designed to bridge the gap between pilot-scale development and full-scale commercial success by providing executive-level experience during critical engineering and commercialization phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ConVergInce Advisers.